CBPD-268

Overview

CBPD-268 is a potent and orally active CBP/p300 PROTAC degrader with an DC 50 value of ≤ 0.03 nM. CBPD-268 induces CBP/p300 degradation and inhibits cell growth. CBPD-268 shows antitumor activity. CBPD-268 has the potential for the research of AR-positive prostate cancer (Structure Note: Red, Androgen receptor degrader ( HY-W248665A ); Blue, CBP/p300 ligand ( HY-161483 ); Black, Linker).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Histone Acetyltransferase

Product Information

• Catalog No.: HY-161369
• CAS No.: 2832961-58-5
• Molecular Formula: C44H47F2N9O5
• Molecular Weight: 819.90
• Purity: 99.23%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source